Ha, Gavin, et al. “Are Patients With HHV-8 Associated Castleman Disease Successfully Treated With Rituximab at Risk of Subsequently Developing HHV-8 Negative (idiopathic) Castleman Disease? IMCD After HHV-8-Associated MCD”. European Journal of Case Reports in Internal Medicine, vol. 10, no. 7, June 2023, https://doi.org/10.12890/2023_003904.